Commerce Dashboard

Ranbaxy Laboratories

Go Back

Ranbaxy Laboratories

  • Serves customers in over 150 countries
  • Over 50 years of experience in providing high quality medicines
  • Product portfolio of over 500 molecules
  • Owns 21 manufacturing facilities spread across eight countries

Ranbaxy Laboratories was established in 1961. It is a research-based international pharmaceutical company serving customers in over 150 countries and has experience of more than 50 years in providing high quality, affordable medicines trusted by healthcare professionals and patients.

Ranbaxy is a member of the Daiichi Sankyo Group which is a leading global pharma innovator, headquartered in Tokyo, Japan.

Ranbaxy has operations in 43 countries and 21 manufacturing facilities spread across eight countries. The company covers all the top 25 pharmaceutical markets of the world and has a robust presence across both developed and emerging markets. Driven by innovation and through their continued focus on research & development (R&D), Ranbaxy has achieved several regulatory approvals in both developed and emerging markets.


Ranbaxy Laboratories: Quality and Patients first

2012 Launches India's first New Chemical Entity (NCE), Synriam
2011 Becomes the first Indian pharmaceutical company to cross global revenues of US$ 2 billion
2010 Launches First-to-File (FTF) product Donepezil hydrochloride tablets; enters golden jubilee year
2008 Redefines business model by bringing in Daiichi Sankyo Co Ltd as a majority partner
2007 Signs a new R&D agreement with GSK and expands drug development responsibilities
2006 Acquires the unbranded generic business of GSK in Italy and Spain
India ranks 3rd worldwide for pharmaceutical production by volume and 14th by value. The country has an established domestic pharmaceutical industry, with a strong network of 3,000 drug companies and ~10,500 manufacturing units.